Enantiomers of quinuclidin-3-ol derivatives: Resolution and interactions with human cholinesterases

Croatica Chemica Acta

Volumn 78, Issue 1, 2005, Pages 121-128

  Bosak, Anita ^a   Primožič, Ines ^b   Oršulić, Mislav ^b   Tomić, Srdanka ^b   Simeon Rudolf, Vera ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Acetylcholinesterase; Butyrylcholinesterase; Chiral quinuclidin 3 ol derivatives; Chiral quinuclidin 3 yl acetates; Chiral substrates and inhibitors; Stereoselectivity of cholinesterases

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; QUINUCLIDINE DERIVATIVE;

ARTICLE; DRUG POTENCY; DRUG SYNTHESIS; ENANTIOMER; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ERYTHROCYTE; HYDROLYSIS; PROTEIN INTERACTION; STEREOCHEMISTRY;

EID: 17144391830     PISSN: 00111643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. M. D. Mashovsky, L. N. Yakhontov, M. E. Kaminka, and E. E. Mikhlina, Prog. Drug. Res. 27 (1983) 9-61.
2. E. Reiner, M. Škrinjarić-Špoljar, S. Dunaj, V. Simeon-Rudolf, I. Primožič, and S. Tomić, Chem. Biol. Interact. 119-120 (1999) 173-181.
3. V. Simeon-Rudolf, E. Reiner, M. Škrinjarić-Špoljar, B. Radić, A. Lucić, I. Primožič, and S. Tomić, Arch. Toxicol. 72 (1998) 289-295.
4. I. Primožič, R. Odžak, S. Tomić, V. Simeon-Rudolf, and E. Reiner, J. Med. Chem. Def., http://www.jmedchemdef.org, 2 (2004) 1-30.
5. B. Radić, A. Lucić, M. Peraica, A.-M. Domijan, and V. Bradamante, Acta. Pharm. 51 (2001) 1-9.
6. B. Ringdahl, R. S. Jope, and D. J. Jenden, Biochem. Pharmacol. 33 (1984) 2819-2822.
7. M. Rehavi, S. Maayani, and M. Sokolovsky, Life Sci. 21 (1977) 1293-1302.
8. Z. Kovarik, Z. Radić, H. A. Berman, V. Simeon-Rudolf, E. Reiner, and P. Taylor, Biochem. J. 373 (2003) 33-40.
9. Z. Kovarik, Z. Radić, H. A. Berman, V. Simeon-Rudolf, E. Reiner, and P. Taylor, Biochemistry 43 (2004) 3222-3229.
10. B. Ringdahl, B. Resul and R. Dahlbom, Acta Pharm. Suec. 16 (1979) 281-283.
11. A. Kalir, E. Sali, and E. Shirin, Isr. J. Chem. 9 (1971) 267-268.
12. V. Simeon-Rudolf and R. T. Evans, Acta Pharm. 51 (2001) 289-296.
13. J. Jensen-Holm, H. H. Lausen, K. Milthers, and O. Møller, Acta Pharmacol. Toxicol. 15 (1959) 384-394.
14. G. L. Ellman, K. D. Courtney, V. Andres, and R. M. Featherstone, Biochem. Pharmacol. 7 (1961) 88-95.
15. M. Dixon and E. C. Webb (Eds.), Enzymes, 3rd ed., Academic Press, New York, 1979, pp. 126-132.
16. W. N. Aldridge and E. Reiner, Enzyme inhibitors as substrates. Interaction of esterases with esters of organophosphorus and carbamic acids, in: E. L. Tatum and I. A. Neuberger (Eds.), Frontiers in Biology, Vol. 26, North-Holland, Amsterdam, 1972.
17. O. Lockridge and P. Masson, Neurotoxicology 21 (2000) 113-126.
18. G. Lambrecht, Arch. Pharm. 315 (1982) 646-651.
19. I. Primožič, T. Hrenar, S. Tomić, and Z. Meić, J. Phys. Org. Chem. 15 (2002) 608-614.
20. I. Primožič, T. Hrenar, S. Tomić, and Z. Meić, Eur. J. Org. Chem. (2003) 295-301.
21. I. Primožič, T. Hrenar, S. Tomić, and Z. Meić, Croat. Chem. Acta 76 (2003) 93-99.
22. A. Ordentlich, D. Barak, G. Sod-Moriah, D. Kaplan, D. Mizrahi, Y. Segall, Ch. Kronman, Y. Karton, A. Lazar, D. Marcus, B. Velan, and A. Shafferman, Biochemistry 43 (2004) 11255-11256.
23. G. Šinko, Z. Radić, P. Taylor, V. Simeon-Rudolf, and E. Reiner, Kinetics of interaction of ethopropazine enantiomers with butyrylcholinesterase and acetylcholinesterase, in: I. Silman, H. Soreq, L. Anglister, D. Michaelson, and A. Fisher (Eds.), Cholinergic Mechanisms: Function and Dysfunction, Taylor and Francis, London, 2004, pp. 795-796.